|
⚲
|
| Keyboard |
| Bios Equity Partners III LP | |
|---|---|
| Firm | Steelhead Capital Management LLC |
| Address | 1751 River Run Suite 400 Fort Worth, TX 76107 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Steelhead Capital Management LLC | |||||
| BIOS Actuate Co-Invest III LP | 021-466668 | Director | 3.2 M | 3.6 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Actuate Therapeutics Inc ACTU
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2025-06-18 | Grant | 34,000 | $0.00 | |
|
In8Bio Inc INAB
Pre-Funded Warrants · derivative
|
2025-05-02 | Buy | 1,148,482 | ||
|
In8Bio Inc INAB
Series A Warrant · derivative
|
2025-05-02 | Other | 574,241 | ||
|
In8Bio Inc INAB
Series B Warrant · derivative
|
2025-05-02 | Other | 574,241 | ||
|
In8Bio Inc INAB
Series A Warrant · derivative
|
2024-10-04 | Grant | 574,241 | ||
|
In8Bio Inc INAB
Pre-Funded Warrants · derivative
|
2024-10-04 | Buy | 709,040 | ||
|
In8Bio Inc INAB
Series C Warrant · derivative
|
2024-10-04 | Buy | 709,040 | ||
|
In8Bio Inc INAB
Series A Warrant · derivative
|
2024-10-04 | Disposed to issuer | 574,241 | ||
|
Actuate Therapeutics Inc ACTU
Series B-2 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 23,628 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 884,427 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Sell | 2,324 | $9.00 | 20,916 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Buy | 125,000 | $8.00 | 1,000,000 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 525,797 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 307,538 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 141,457 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 462,073 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 61,857 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 153,702 | ||
| showing 20 of 160 most recent transactions | |||||